Roivant Sciences Ltd. Common Shares (ROIV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ROIV. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 172 institutions reported holding ROIV, with 316.7 million shares worth $11.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 85,575,553 | $3.1B | INCREASED |
| BlackRock | 61,879,232 | $2.3B | INCREASED |
| Morgan Stanley | 38,603,606 | $1.4B | DECREASED |
| Vanguard | 25,062,337 | $917M | INCREASED |
| State Street | 22,399,587 | $819M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mayukh Sukhatme (President & CIO) | TAX-W | 1,737 | $73K | 2026-11-12 |
| Mayukh Sukhatme (President & CIO) | OTHER | 8,482 | $349K | 2026-11-12 |
| Mayukh Sukhatme (President & CIO) | OTHER | 44,723 | $2M | 2026-11-12 |
| Matthew Gline (CEO) | TAX-W | 1,600 | $67K | 2026-11-12 |
| Matthew Gline (CEO) | OTHER | 7,809 | $321K | 2026-11-12 |
Full institutional holdings, insider history, and congressional trades for Roivant Sciences Ltd. Common Shares on SentiSense.